Patanjali Foods Ltd (BOM:500368)
₹ 1859.3 5.95 (0.32%) Market Cap: 673.06 Bil Enterprise Value: 656.34 Bil PE Ratio: 67.69 PB Ratio: 6.21 GF Score: 83/100

Q1 2025 Patanjali Foods Ltd Earnings Call Transcript

Jul 22, 2024 / 04:00AM GMT
Release Date Price: ₹1606.75 (+0.98%)

Key Points

Positve
  • Revenue from operations stood at INR7,173 crores, showing strong growth.
  • Total EBITDA grew by 105.2% year-on-year to INR435 crores.
  • PAT nearly tripled to INR262.91 crores with PAT margins at 3.65%.
  • Edible oil segment recorded healthy margins of 4.35%, better than the standard range.
  • Initiation of acquiring Patanjali Ayurved Ltd's home and personal care business, expected to enhance stability and growth.
Negative
  • Revenue from the food and FMCG segment declined by INR751 crores quarter-on-quarter.
  • Edible oil segment faced downward pricing pressure and a slight dip in demand due to unfavorable weather conditions.
  • Employee costs increased by almost 50% due to ESOP allocations.
  • Depreciation and other expenditures showed volatility, impacting financial stability.
  • Nutraceuticals segment was marginally negative, still not covering costs.
Operator

Ladies and gentlemen, good day and welcome to the Patanjali Foods Ltd. Q1 FY25 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Sanjeev Asthana, CEO from Patanjali Foods Ltd Thank you and over to you, sir.

Sanjeev Asthana
Patanjali Foods Ltd - Chief Executive Officer

Thank you very much. Good morning, welcome and thank you for joining us today for Patanjali Foods Ltd.'s call to discuss the results of Q1 FY25. I am joined by the company's CFO, Mr. Kumar Rajesh, along with Mr. Priyendu Jha and Mr. Chintan Kotak from the IR team. The team from our investor relations advisor, the strategic growth advisors is also here.

We have uploaded the results collateral on the stock exchange as well as the company's website for your reference. Please note that the call we will be referring to on standalone financials.

I am pleased to share that we have begun this fiscal on a favorable note with strong growth and profitability metrics. During Q1 FY25, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot